scholarly article | Q13442814 |
P356 | DOI | 10.1002/TCR.201600141 |
P698 | PubMed publication ID | 28266174 |
P2093 | author name string | Irishi N N Namboothiri | |
T V Baiju | |||
P2860 | cites work | Photophysical and electrochemical properties of heteroleptic tris-cyclometalated iridium(III) complexes | Q46552567 |
Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2''-hydroxy naphthalen-1''-yl)-1,5-diphenyl-2-pyrazolines | Q46708071 | ||
Constituents of the stem bark of Discopodium penninervium and their LTB4 and COX-1 and -2 inhibitory activities | Q46845612 | ||
Blue-emitting platinum(II) complexes bearing both pyridylpyrazolate chelate and bridging pyrazolate ligands: synthesis, structures, and photophysical properties | Q46890117 | ||
Luminescence rigidochromism and redox chemistry of pyrazolate-bridged binuclear platinum(II) diimine complex intercalated into zirconium phosphate layers | Q50252833 | ||
Tetrahedral zinc complexes with liquid crystalline and luminescent properties: interplay between nonconventional molecular shapes and supramolecular mesomorphic order. | Q50465816 | ||
A novel synthesis of fluorinated pyrazoles via gold(I)-catalyzed tandem aminofluorination of alkynes in the presence of Selectfluor. | Q50516190 | ||
Copper-Catalyzed Coupling of 2-Siloxy-1-alkenes and Diazocarbonyl Compounds: Approach to Multisubstituted Furans, Pyrroles, and Thiophenes. | Q50633385 | ||
TEMPO-mediated aliphatic C-H oxidation with oximes and hydrazones. | Q51200778 | ||
An efficient one pot regioselective synthesis of a 3,3'-spiro-phosphonylpyrazole-oxindole framework via base mediated [1,3]-dipolar cycloaddition reaction of the Bestmann-Ohira reagent with methyleneindolinones. | Q53182329 | ||
Regioselective cycloaddition of trifluorodiazoethane with electron-deficient allenic esters and ketones: access to CF3-substituted pyrazolines and pyrazoles. | Q53545150 | ||
Regioselective synthesis of 1,3,5-trisubstituted pyrazoles from N-alkylated tosylhydrazones and terminal alkynes. | Q54342658 | ||
One-pot three-component approach to the synthesis of polyfunctional pyrazoles. | Q54567433 | ||
Ruthenium-catalyzed C-H functionalization of arylpyrazoles: regioselective acylation with acid chlorides. | Q54654632 | ||
Organic Synthesis with .alpha.-Diazo Carbonyl Compounds | Q55980093 | ||
Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction | Q56067856 | ||
Recent Advances in the Chemistry of Pyrazoles. Part 2. Reactions and N-Heterocyclic Carbenes of Pyrazole | Q56806037 | ||
Enantioselective Synthesis of Dihydropyrazoles by Formal [4+1] Cycloaddition of in Situ-Derived Azoalkenes and Sulfur Ylides | Q57404795 | ||
Efficient Synthesis of Pyrazoles: Oxidative CC/NN Bond-Formation Cascade | Q57657389 | ||
Rhodium(I)-N-Heterocyclic Carbene Catalyst for Selective Coupling of N-Vinylpyrazoles with Alkynes via C–H Activation | Q57835487 | ||
Reagent-Controlled Oxidative Aromatization in Iodocyclization: Switchable Access to Dihydropyrazoles and Pyrazoles | Q58007672 | ||
Current status of pyrazole and its biological activities | Q26767080 | ||
Synthetic methods for azaheterocyclic phosphonates and their biological activity | Q35976200 | ||
Anticarcinogenic properties of garlic: a review | Q35992022 | ||
Synthesis of beta-aminophosphonates and -phosphinates | Q36065166 | ||
Vinyl sulfones: synthetic preparations and medicinal chemistry applications | Q36513885 | ||
A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms | Q36660335 | ||
Synthesis and biological activity of phosphonated nucleosides: part 1. Furanose, carbocyclic and heterocyclic analogues | Q36683508 | ||
Conversion of carbonyl compounds to alkynes: general overview and recent developments. | Q37760823 | ||
Sulfones: new reagents in organocatalysis | Q37760824 | ||
From 2000 to mid-2010: a fruitful decade for the synthesis of pyrazoles | Q37909306 | ||
Developments in synthesis of the anti-inflammatory drug, celecoxib: a review | Q38097071 | ||
Pyrazole containing natural products: synthetic preview and biological significance. | Q38150028 | ||
The therapeutic voyage of pyrazole and its analogs: A review. | Q38559961 | ||
Modern Organic Synthesis with α-Diazocarbonyl Compounds. | Q38568966 | ||
Homologation Reaction of Ketones with Diazo Compounds | Q38725903 | ||
Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids. | Q38752997 | ||
Copper-promoted cycloaddition of diazocarbonyl compounds and acetylides | Q42584705 | ||
Three-component reaction using the Bestmann-Ohira reagent: a regioselective synthesis of phosphonyl pyrazole rings | Q43116049 | ||
Phosphonylpyrazoles from Bestmann-Ohira reagent and nitroalkenes: synthesis and dynamic NMR studies | Q43135621 | ||
A divergent strategy to the withasomnines | Q43274948 | ||
The total synthesis of withasomine, a unique pyrazole alkaloid | Q43405840 | ||
Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines | Q43722079 | ||
Syntheses and phosphorescent properties of blue emissive iridium complexes with tridentate pyrazolyl ligands | Q43893261 | ||
Copper-catalyzed aerobic intramolecular dehydrogenative cyclization of N,N-disubstituted hydrazones through C(sp(3)-H functionalization. | Q45815968 | ||
Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates | Q46376078 | ||
P921 | main subject | cycloaddition | Q898648 |
P577 | publication date | 2017-03-07 | |
P1433 | published in | The Chemical Record | Q3520251 |
P1476 | title | Synthesis of Functionalized Pyrazoles via 1,3-Dipolar Cycloaddition of α-Diazo-β-ketophosphonates, Sufones and Esters with Electron-Deficient Alkenes |
Q92933653 | Synthesis of Functionalized Thieno[2,3-b]indoles via One-Pot Reaction of Indoline-2-thiones with Morita-Baylis-Hillman and Rauhut-Currier Adducts of Nitroalkenes | cites work | P2860 |
Search more.